Literature DB >> 20061159

Utilization of the 1,2,3,5-thiatriazolidin-3-one 1,1-dioxide scaffold in the design of potential inhibitors of human neutrophil proteinase 3.

Dengfeng Dou1, Guijia He, Yi Li, Zhong Lai, Liuqing Wei, Kevin R Alliston, Gerald H Lushington, David M Eichhorn, William C Groutas.   

Abstract

The S' subsites of human neutrophil proteinase 3 (Pr 3) were probed by constructing diverse libraries of compounds based on the 1,2,3,5-thiatriazolidin-3-one 1,1-dioxide using combinational and click chemistry methods. The multiple points of diversity embodied in the heterocyclic scaffold render it well-suited to the exploration of the S' subsites of Pr 3. Molecular modeling studies suggest that further exploration of the S' subsites of Pr 3 using the aforementioned heterocyclic scaffold may lead to the identification of highly selective, reversible competitive inhibitors of Pr 3. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20061159      PMCID: PMC2853038          DOI: 10.1016/j.bmc.2009.12.057

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  53 in total

Review 1.  The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years.

Authors:  Steven D Shapiro; Edward P Ingenito
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05       Impact factor: 6.914

Review 2.  Neutrophil serine proteases: specific regulators of inflammation.

Authors:  Christine T N Pham
Journal:  Nat Rev Immunol       Date:  2006-07       Impact factor: 53.106

Review 3.  Neutrophil elastase: mediator of extracellular matrix destruction and accumulation.

Authors:  Felix Chua; Geoffrey J Laurent
Journal:  Proc Am Thorac Soc       Date:  2006-07

4.  Substrate and inhibitor studies on proteinase 3.

Authors:  C M Kam; J E Kerrigan; K M Dolman; R Goldschmeding; A E Von dem Borne; J C Powers
Journal:  FEBS Lett       Date:  1992-02-03       Impact factor: 4.124

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

Review 6.  Mediators of chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Pharmacol Rev       Date:  2004-12       Impact factor: 25.468

Review 7.  Pathogenesis of PR3-ANCA associated vasculitis.

Authors:  C G M Kallenberg
Journal:  J Autoimmun       Date:  2007-12-26       Impact factor: 7.094

8.  Mechanism-based inhibitors of serine proteases with high selectivity through optimization of S' subsite binding.

Authors:  Yi Li; Dengfeng Dou; Guijia He; Gerald H Lushington; William C Groutas
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

9.  Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

Authors:  Joie Garfunkle; Cyrine Ezzili; Thomas J Rayl; Dustin G Hochstatter; Inkyu Hwang; Dale L Boger
Journal:  J Med Chem       Date:  2008-07-16       Impact factor: 7.446

10.  Human neutrophil proteinase 3: mapping of the substrate binding site using peptidyl thiobenzyl esters.

Authors:  M J Brubaker; W C Groutas; J R Hoidal; N V Rao
Journal:  Biochem Biophys Res Commun       Date:  1992-11-16       Impact factor: 3.575

View more
  2 in total

1.  Design, Synthesis and Cytotoxicity of Thiazole-Based Stilbene Analogs as Novel DNA Topoisomerase IB Inhibitors.

Authors:  Jin-Chuan Liu; Bo Chen; Jia-Lin Yang; Jian-Quan Weng; Qian Yu; De-Xuan Hu
Journal:  Molecules       Date:  2022-02-02       Impact factor: 4.411

2.  An expeditious and efficient bromomethylation of thiols: enabling bromomethyl sulfides as useful building blocks.

Authors:  Carolina Silva-Cuevas; Ehecatl Paleo; David F León-Rayo; J Armando Lujan-Montelongo
Journal:  RSC Adv       Date:  2018-07-10       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.